Rockefeller Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$980 Buy
2022
Q4
Sell
2022
Q3
$41K Hold
2022
Q2
$21K Buy